文献速递乳房整形与再造瘢痕与激光

经腋窝乳房增大术后瘢痕感知与结局的前瞻性分析

Scar Perception and Outcomes After Transaxillary Breast Augmentation: A Prospective Analysis of Patient- and Observer-Reported Scar Quality.
PubMed 文献 · Aesthet Surg J · 2025-01-01

该前瞻性队列纳入71例经腋窝乳房增大术患者共142条腋窝切口,平均随访58.3个月,用POSAS v2.0在术后1、6、12个月评估瘢痕。11例(15.4%)发生至少1种并发症,最常见为腋窝束带感(4.2%);术后12个月最差评分为颜色(均值2.35),81%患者和78.2%观察者总体评分属低/中级。

要点

  • 71例患者142条腋窝切口,平均随访58.3个月,15.4%发生至少1种并发症。
  • 术后12个月颜色评分最差(均值2.35,范围1-6),81%患者和78.2%观察者总体评分为低/中级。
  • 毛面假体、假体体积>350 cc及未使用假体套袖与1年POSAS总体高/极高评分显著相关(均P<.001)。

核心结论

  • 经腋窝乳房增大术是可靠技术,POSAS评估显示多数患者术后1年结果满意、POSAS评分较低。
  • 充分的术前规划和切口 placement 可使外科医生安全实施该技术并减少不良瘢痕结局风险。

研究设计与样本

  • 前瞻性队列研究,纳入接受经腋窝乳房增大术的患者,共71例、142条腋窝切口。
  • 采用患者与观察者瘢痕评估量表(POSAS)v2.0在术后1、6、12个月评估瘢痕结局。

主要发现

  • 队列平均(标准差)年龄28.1(6.1)岁,平均随访58.3(28.6)个月。
  • 11例患者(15.4%)经历至少1种并发症,最常见为腋窝束带感(4.2%)。
  • 腋窝切口平均长度37.1 mm(范围25-66 mm)。
  • 未使用假体套袖(P<.001)、使用毛面假体(P<.001)及假体体积>350 cc(P<.001)与更大的切口相关。
  • 术后12个月最差评分与颜色相关(均值2.35,范围1-6),81%患者和78.2%观察者总体评分属低/中级。

关键数值与推荐

  • 并发症:11例(15.4%)发生至少1种并发症,腋窝束带感最常见(4.2%)。
  • 切口长度:平均37.1 mm(范围25-66 mm)。
  • 术后12个月颜色评分均值2.35(范围1-6),81%患者和78.2%观察者总体评分为低/中级。
  • 与1年POSAS总体高/极高评分相关的危险因素:毛面假体、假体体积>350 cc、未使用套袖(均P<.001)。

临床怎么用

  • 作者认为经腋窝乳房增大术是可靠技术,充分的术前规划和切口 placement 可安全实施并减少不良瘢痕结局风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The transaxillary (TAA) approach offers breast augmentation (BA) with inconspicuous scarring. Previous investigations of scar outcomes have involved limited follow-up/samples, and no clinical studies have specifically assessed scars with scar-specific instruments. OBJECTIVES: The primary aim of this study was to evaluate axillary incision and associated complications with TAA BA. METHODS: A cohort of patients who underwent TAA BA was identified. Scar outcome was evaluated with the Patient and Observer Scar Assessment Scale (POSAS) v. 2.0 at 1-, 6-, and 12-month study endpoints. RESULTS: The cohort contained 71 patients (mean [standard deviation] age, 28.1 [6.1] years) and 142 axillary incisions, with average follow-up of 58.3 [28.6] months. Eleven patients (15.4%) experienced at least 1 complication, most frequently axillary banding (4.2%). The mean axillary incision length was 37.1 mm (range, 25-66 mm). Nonuse of implant sleeves (P < .001), the use of textured-surface implants (P < .001), and implant volume >350 cc (P < .001) were associated with larger incisions. At 12 months the poorest scores were related to color (mean, 2.35; range, 1-6), and 81% and 78.2% of patient and observer opinion scores were low/intermediate grade, respectively. Textured-surface implants (P < .001), implant volume >350 cc (P < .001), and nonuse of sleeve (P < .001) were significant risk factors for high/very-high POSAS overall scores at 1-year follow-up. CONCLUSIONS: Despite extensive research on BA procedures, studies on the TAA are limited and have not analyzed long-term incision-related outcomes. The data obtained in this study demonstrate that the TAA is a reliable technique, and POSAS evaluations showed that most patients presented satisfactory results and higher satisfaction with lower POSAS scores at 1 year postsurgery. Adequate preoperative planning and incision placement allows surgeons to perform this technique safely while minimizing risks of poor scar outcome.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Munhoz AM. Scar Perception and Outcomes After Transaxillary Breast Augmentation: A Prospective Analysis of Patient- and Observer-Reported Scar Quality. Aesthet Surg J. 2025. PMID: 40181516. doi:10.1093/asj/sjaf052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。